Darmstadt, Germany – The Personnel Committee of E. Merck KG, Darmstadt, Germany, has decided on changes in the responsibilities of the Executive Board of Merck KGaA, Darmstadt, Germany, effective September 1, 2017. Walter Galinat (61) will hand over responsibility for the Performance Materials business of Merck KGaA, Darmstadt, Germany, to his Executive Board colleague Kai […]
We are very pleased and proud to announce the appointment of Mr. Yoichi Horie as new President and Chief Executive Officer of Yamato Scientific America Inc. effective August 1, 2017. A Japanese national from the Central Region, Horie has more than 20 years experience in the scientific instrument industry. Prior to joining Yamato, he was […]
The Board of Halma, the leading safety, health and environmental technology group, announces that, further to its 6 April 2017 announcement, Marc Ronchetti, currently Group Financial Controller, will succeed Kevin Thompson as Group Finance Director. Kevin Thompson will continue as Group Finance Director until the recruitment of Marc’s successor as Group Financial Controller is completed […]
Two-day workshop underscores NIH’s increasing interest in applying QSP methods to facilitate development of CNS therapies PRINCETON, NJ – Certara®, the global leader in model-informed drug development and regulatory science, today announced that Professor Piet van der Graaf, PharmD, PhD, vice president and head of Certara QSP, is co-chairing the NIH workshop entitled “QSP and Drug […]
Dayton, OH — Yaskawa Motoman is pleased to announce that Doug Burnside has been appointed Vice President of North American Sales and Marketing. In this position, Burnside will be responsible for establishing and executing strategic business direction to drive growth in the North American market, as well as leadership for all sales and marketing activities. […]
Executive Board Members Monz and Metz will also continue OBERKOCHEN/Germany The Supervisory Board of Carl Zeiss AG has decided to continue the appointment of Dr. Michael Kaschke as President & CEO until 30 June 2020. Kaschke joined the ZEISS Group 25 years ago and has served on the Executive Board since 2000. He has been […]
CEO of Juno Therapeutics brings deep knowledge of the biopharma industry SANTA CLARA, Calif. Agilent Technologies, Inc. (NYSE: A) today announced that Hans E. Bishop, CEO of Juno Therapeutics, has been elected to its board of directors. Bishop co-founded Juno Therapeutics, a Seattle-based biopharmaceutical company, in 2013. As president and CEO, Bishop leads Juno as […]
LANSING, Mich. — Neogen Corporation (NASDAQ: NEOG) announced today the company has named John Adent as chief executive officer, effective immediately. James Herbert, the company’s founder and former CEO, will remain as executive chairman and work closely with Adent in the transition of responsibilities. “I’m excited to have John accept the leadership position at our company. […]
On July 1st, Biotage expanded its direct sales organization and opened the door to analytical customers in Italy. Account Manager Gianluca Pessoni is added to the Italian team, filling the analytical gap and enabling full support for the entire product range to Italian customers. Within the analytical chemistry field, Biotage AB and its Italian distributor […]
Professor Dressman’s appointment enhances Certara’s biopharmaceutics and bioequivalence expertise PRINCETON, NJ – Certara®, the global leader in model-informed drug development and regulatory science, today announced that Professor Jennifer B. Dressman, PhD, has been appointed to the Simcyp® Scientific Advisory Board (SAB) to further strengthen its status in the biopharmaceutics field. An expert in biopharmaceutics and a […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
